Recommended Free Tools
CBL-514 is an experimental injection designed to trigger fat-cell death. A 2026 conference abstract reports that, in an MRI subset of 46 people, measured visceral fat volume fell more with CBL-514 than with placebo over several weeks. That is an early body-composition result—not evidence that the drug prevents diabetes or heart disease, produces lasting weight loss, or is available as a routine treatment.
How CBL-514 is supposed to work
CBL-514 is described as an adipocyte-apoptosis-inducing injection. Adipocytes are fat cells; apoptosis is a regulated process of cell death. The idea differs from approaches that aim simply to make fat cells smaller, but the mechanism alone does not establish that treatment is safe, durable, or beneficial to health.
As an Amazon Associate I earn from qualifying purchases.
CBL-514 remains experimental. The available reports do not establish routine clinical availability or regulatory authorization.
Quick wins for a faster PC:
Scan for outdated or missing drivers - takes under a minuteDriver Scan →Clear out junk files and repair common Windows errorsFree Scan →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →What the visceral-fat study measured
At the 2026 European Association for the Study of Diabetes (EASD) meeting in Milan, Ling and coauthors presented a one-page conference abstract analyzing MRI data from a subset of participants in two Phase 2 studies, CBL-0204 and CBL-0205. The analysis included 26 people who received CBL-514 and 20 who received placebo. Participants had a BMI of 22–30 kg/m² and had changed less than 3 kg in weight. Researchers used an AI-assisted method to estimate visceral adipose tissue (VAT) volume at the L2-L3 level—a specific region of the abdomen.
#1 Best Overall
- CLA LEAN BODY FAT REDUCTION - CLA Lean Body Fat Reduction supplies 3400 mg of CLA per maximum daily dose to support healthy weight management. It also delivers a combination of “next-generation” oils that are known for promoting health & vitality.
- POWERED BY CLA - CLA (Conjugated Linoleic Acid) is a slightly modified form of the Omega-6 essential fatty acid: Linoleic Acid. This healthy fat is found in small quantities in grass-fed meat and dairy products.
- SUPPORTED BY SCIENCE - Studies have shown that CLA blocks a portion of the body’s fat-storing enzyme (called lipoprotein lipase), which supports a decrease in body fat and an increase in muscle tissue (lean body mass).
- ADVANCED DELIVERY SYSTEM - Our easy-to-swallow liquid soft-gels utilize an optimum delivery system, which includes our special BioPerine Complex to enhance the bioavailability, absorption, and potency of many nutrients.
- QUALITY ASSURANCE - As a leader in innovation and research, Irwin Naturals is committed to providing outstanding, highest quality products for your health and well-being. We employ compliance testing to ensure purity and potency.
At baseline, average measured VAT volume was 642.5 mL in the CBL-514 group and 677.4 mL in the placebo group; the abstract reports no significant difference between groups at that point. The reported changes were:
| Measurement | CBL-514 | Placebo | Placebo-adjusted comparison |
|---|---|---|---|
| Week 4 mean VAT-volume change | −65.5 mL (−10.9%) | +29.4 mL (+4.6%) | −94.9 mL by t-test (p=0.0015); −73.4 mL by Hodges–Lehmann estimation (p=0.0009) |
| Week 8–12 mean VAT-volume change | −58.1 mL (−7.3%) | +79.4 mL (+18.4%) | −137.5 mL by t-test (p=0.0015); −116 mL by Hodges–Lehmann estimation (p=0.0020) |
These are distinct statistics: the first two columns show each group’s average change from its own baseline; the final column gives the estimated difference between groups using two methods. They should not be conflated. The abstract does not provide a full peer-reviewed report of this visceral-fat analysis with complete methods and safety details. Ling et al., EASD Annual Meeting abstract, 2026.
Rank #2
- Advanced Fat-Burning Formula: Dr. Vitamin’s women’s fat-burner & appetite-control supplements feature a blend of herbal extracts, botanicals, and essential nutrients that enhance energy & metabolism to support appetite control and weight loss.
- Stay Energized & Focused All Day: Stay active and alert with a powerful fusion of MCT Oil, CoQ10, Kelp, and Vitamin B6. This fat burner for women and men helps burn fat while providing sustained jitter-free energy to keep you active, focused, and motivated.
- Metabolism Booster for Weight Loss: Boost your body's natural fat-burning process with L-Carnitine, CLA, and Chromium. These weight-loss pills for women's belly fat convert stored fat into energy, promoting efficient calorie burning and enhancing metabolism.
- Suppress Hunger & Cravings: Curb cravings and reduce snacking with Garcinia Cambogia and Gymnema Sylvestre. This appetite suppressant for weight loss regulates hunger and supports portion control, making it easier to stay on track with your weight-loss goals in conjunction with a healthy diet and exercise.
- Trusted Quality: Made for fitness enthusiasts, our weight loss supplements for men & women come with 30 non-GMO capsules. These diet pills work fast for women and are clinically tested & made in a GMP-certified facility to ensure safety.
Visceral fat is not the same endpoint as abdominal subcutaneous fat
Visceral fat lies within the abdomen around internal organs. Subcutaneous fat is the fat beneath the skin. The 2026 MRI abstract concerns estimated L2-L3 VAT volume; it is separate from an earlier peer-reviewed Phase 2 study of abdominal subcutaneous fat. Results from one body-fat compartment cannot be treated as results for the other.
Windows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallOutdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchWhat the separate 2025 study found
Gold and colleagues reported a randomized, single-blind, placebo-controlled study in the Aesthetic Surgery Journal in 2025. It randomized 76 participants 2:1 and tested up to four abdominal subcutaneous treatments spaced four weeks apart. Its primary endpoint was whether participants had at least 150 mL less subcutaneous fat volume than at baseline, assessed eight weeks after the final treatment.
Rank #3
- Extreme Caution Advised: This is the strongest LIPO-6 fat burner product we have ever released. Just one pill will set the stage for extreme fat loss effects.
- Thermogenic Fat Burner: Lipo6 Black Ultra Concentrate is a powerful fat burner for men and women designed to target stubborn fat and help rapidly destroy unwanted fat deposits.
- Fast Acting Liqui-Capsule: This potent fat loss supplement goes to work fast, increasing thermogenesis, burning fat for fuel and increasing energy while also containing key compounds that further work as a metabolism booster for weight loss.
- Appetite Suppressant: All in one weight loss supplement does more than burn fat. It also provides an appetite suppressant for weight loss to help make it easier to manage your food intake and control cravings, reducing the amount of calories you consume.
- Powerful Ingredients: One main reason people give up on their diet is due to a lack of energy and motivation. Lipo-6 includes proven ingredient Teacrine designed to support motivation, decrease fatigue and lasting energy without the crash
In the intention-to-treat results, 69.6% of the CBL-514 group and 0% of the placebo group reached that endpoint (P<.001). Injection-site reactions were the most common treatment-emergent adverse events and were described as mild to moderate. Follow-up was short, and attrition was substantial: of the 75 participants treated, 38 completed the study. Caliway Biopharmaceuticals sponsored the study and participated in its design, data collection, analysis, interpretation, manuscript writing, and decision to submit. Gold et al., Aesthetic Surgery Journal, published March 4, 2025.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What the results do—and do not—show
- What they show: In a selected MRI subset, measured L2-L3 VAT volume was lower with CBL-514 than at baseline, while it was higher with placebo at the reported follow-ups. The abstract reports statistically significant between-group comparisons.
- What they do not show: The abstract reports no diabetes incidence, cardiovascular events, insulin-sensitivity results, or other clinical health outcomes. Its suggestion of possible future metabolic benefits is a possibility, not an outcome demonstrated by these measurements.
- What remains uncertain: Data from 46 people and follow-up to 8–12 weeks cannot establish long-term effectiveness, durability, broader applicability, or uncommon harms. The available sources do not include a full report of the visceral-fat analysis.
- What should not be combined: The 2025 subcutaneous-fat trial and the 2026 visceral-fat MRI analysis tested different endpoints and are reported in different forms—a peer-reviewed study and a conference abstract, respectively.
Science News also summarized the visceral-fat findings, describing the analysis as a subset of two small trials and noting that larger efficacy and safety studies were ongoing. Its rounded account of the four-week changes differs slightly from the abstract; the primary abstract is the source for the exact figures above. Science News, “An experimental drug kills fat cells, rather than shrinking them,” accessed October 8, 2026.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
